SCHEMBL12278482

SCHEMBL12278482

COc1cc2cc3c(ccc4c5cc6ccoc6cc5ccc34)cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.41
▸ KDM4E B2RXH2 5/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ CYP2A6 P11509 4/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ MAOA P21397 3/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ PTPN1 P18031 2/20 0.40
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ADORA3 P0DMS8 4/20 0.35
▸ CYP1A1 P04798 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ PGR P06401 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12278631 0.94 CYP3A4 (0.44) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12277942 0.89 MCL1 (0.37) KDM4EHSD17B10CYP2A6CASP1CASP7
SCHEMBL12278442 0.82 PIM1 (0.39) KDM4EHSD17B10CYP2A6ACHEPTPN1
SCHEMBL12278698 0.80 CYP2A6 (0.47) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12277889 0.80 CYP3A4 (0.44) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12278490 0.78 CYP3A4 (0.41) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12277919 0.77 MAOA (0.42) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12278533 0.77 CYP2A6 (0.44) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12321283 0.77 CYP2A6 (0.46) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6
SCHEMBL12278742 0.77 KDM4E (0.41) CYP3A4KDM4EHSD17B10CYP2A6CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785915-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-07-22 — — US disclosed
US-8785915-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-07-22 — — US disclosed
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) 2011-09-01 — — US disclosed
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) 2011-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME OR10J3, TCF4, CTCF CYP3A4 165/4885KDM4E 667/4885HSD17B10 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback